What You Should Know:
- Unnatural Products, Inc. (UNP), a biotech company harnessing the power of AI and chemistry to design the next generation of targeted therapeutics, has secured $32M in Series A funding.
- Led by Merck Global Health Innovation Fund (MGHIF) and TechBio-focused ARTIS Ventures, the funding will help propel UNP's innovative platform and expand its reach beyond oncology, tackling a wider range of medical challenges.
Macrocycles: Nature's Key to Untapped Drug
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
ARTIS Ventures Closes $200M TechBio Fund to Support Next Era of Health & Medicine Innovation
What You Should Know:
- ARTIS Ventures, a pioneer in this "TechBio" revolution, announces the closing of its second fund, TechBio II, with $200M focused on healthcare and biology innovation.
- The fund aims to support early-stage companies to transform human health and well-being by leveraging growing data sets, advanced analytics, and insights.
TechBio II Investment Thesis
Diseases once deemed incurable now have hope, personalized therapies are becoming a reality, and the human body
Read More
AstraZeneca Acquires Icosavax for $1.1B to Advance RSV and hMPV Vaccine Development
What You Should Know:
- AstraZeneca has announced the acquisition of Icosavax, a biopharmaceutical company developing a promising vaccine targeting both RSV and hMPV, for a total of up to $1.1 billion.
- This acquisition strengthens AstraZeneca's respiratory pipeline and aligns with their strategy of addressing high unmet needs in infectious diseases.
Building on Expertise in RSV Prevention
Icosavax's lead program, IVX-A12, is a Phase III-ready vaccine candidate targeting both
Read More
Medtronic Expands AI-Driven Partnership with Cosmo Pharmaceuticals to Transform Endoscopy
What You Should Know:
- Medtronic announced an expanded AI partnership with Cosmo Pharmaceuticals NV, a pharmaceutical company, to further advance AI-powered solutions in the medical field.
- This strategic alliance builds upon the success of the GI Genius™ intelligent endoscopy module, aiming to revolutionize endoscopy through AI and improve patient outcomes globally.
Partnership Benefits
Building upon the success of the GI Genius™ intelligent endoscopy module, the partnership will
Read More
Veradigm Announces Leadership Changes and Ongoing Investigation
What You Should Know:
- Veradigm Inc. announced significant leadership changes and an ongoing investigation into the company's financial reporting. The Audit Committee is conducting an independent investigation relating to the company's financial reporting, internal controls, and disclosure controls. The potential impact on previously reported financial statements is under review.
- The Board of Directors has initiated a search process for a permanent CEO and CFO. The company previously
Read More
Yseop Secures Investment to Accelerate Generative AI Content Automation for Pharma
What You Should Know:
Yseop, a world-leading Generative AI company for life sciences, today announces the closing of a strategic investment round, with new investor Novartis (dRx Capital), joining existing investors Eli Lilly, NextStage AM and Wille Finance and celebrates its involvement in more than 150 clinical trials across the leading pharmaceutical companies in the world.Included in these clinical trials are many of the most notable advancements in new treatments, vaccines, and medicines
Read More
Insights Management: A New Paradigm for Cancer Treatment
The cancer market for the pharma industry accounts for about a third of their product pipeline. With oncology drug sales set to top $390 billion by 2027, life science companies are aligning efforts to prioritize this critical market opportunity ahead of competitors.
The field of cancer presents unique challenges for the pharmaceutical industry, requiring innovative solutions to address high demand, intense competition, expensive research and development (R&D), complexities in drug
Read More
Cytovale Secures $84M for Transformative Sepsis Diagnostic Tool
What You Should Know:
Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced it has raised $84 million in Series C funding led by Norwest Venture Partners with participation by additional new investors Sands Capital and Global Health Investment Corporation (GHIC).The financing included participation from other new and existing investors, as well as the conversion of
Read More
Absci and AstraZeneca Sign $247M Partnership for AI-Powered Drug Discovery to Fight Cancer
What You Should Know:
- Absci Corporation (ABSI), a pioneer in using generative AI to discover antibodies, and AstraZeneca, a global biopharmaceutical leader, announced a collaboration today to develop an AI-designed antibody for cancer.
- This partnership combines Absci's cutting-edge Integrated Drug Creation™ platform with AstraZeneca's oncology expertise, aiming to accelerate the discovery of a potential new cancer treatment.
Absci's AI Engine Takes the Lead
Absci will leverage
Read More
PerkinElmer Acquires Covaris to Create Global Life-Sciences and Diagnostics Platform
What You Should Know:
- PerkinElmer, a leading global analytical services and solutions provider, announced its acquisition of Covaris, a developer of solutions for life science innovations.
- This strategic move will fuel Covaris' growth and expand PerkinElmer's life sciences portfolio into the high-growth diagnostics market. Notably, both companies share majority ownership under New Mountain Capital, making the integration potentially smoother. While financial details remain undisclosed,
Read More
